Knowledge Hub

Global Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Clinical Trials Review, H2, 2016

Press Release   •   Nov 21, 2016 06:16 EST

GlobalData's clinical trial report, Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H2, 2016" provides an overview of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) clinical trials scenario. This report provides top line data relating to the clinical trials on Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

View Report At http://www.marketresearchreports.biz/analysis/871693

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

Download Sample copy of this Report at : http://www.marketresearchreports.biz/sample/sample/871693

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Five Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by G7 Countries: Proportion of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) to Cardiovascular Clinical Trials 16

Clinical Trials by Phase in G7 Countries 18

Clinical Trials in G7 Countries by Trial Status 19

Clinical Trials by E7 Countries: Proportion of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) to Cardiovascular Clinical Trials 20

Clinical Trials by Phase in E7 Countries 22

Clinical Trials in E7 Countries by Trial Status 23

Clinical Trials by Phase 24

In Progress Trials by Phase 25

Clinical Trials by Trial Status 26

Clinical Trials by End Point Status 27

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials 32

Prominent Drugs 34

Latest Clinical Trials News on Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) 35

Oct 04, 2016: AstraZeneca reports top-line results from the Brilinta EUCLID trial in patients with peripheral artery disease 35

Sep 29, 2016: Low levels of endogenous anti-PC identified as a novel risk factor for vein bypass graft failure and cardiovascular complications in PAD patients 35

Sep 28, 2016: Athera presents positive First-in-Patient data with their new antibody against immunovascular disease at ESVS 36

Aug 11, 2016: Athera Biotechnologies completes First-in-Patient Study with New Antibody Against Immunovascular Disease 36

Clinical Trial Profile Snapshots 37

Appendix 270

Abbreviations 270

Definitions 270

Research Methodology 271

Secondary Research 271

About GlobalData 272

Contact Us 272

Disclaimer 272

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.